Design of novel iron compounds as potential therapeutic agents against tuberculosis

Journal of Inorganic Biochemistry

Volumn 104, Issue 11, 2010, Pages 1164-1170

  Tarallo, M Belén ^a   Urquiola, Carolina ^a   Monge, Antonio ^b   Costa, Beatriz Parajón ^c   Ribeiro, Ronny R ^d   Costa Filho, Antonio J ^d   Mercader, Roberto C ^c   Pavan, Fernando R ^e   Leite, Clarice Q F ^e   Torre, María H ^a   Gambino, Dinorah ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b UNIVERSITY OF NAVARRA   (Spain)

^c FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Iron; Mycobacterium tuberculosis; Quinoxaline N1,N4 dioxides; Tuberculosis

Indexed keywords

(3 AMINO 6 (7) CHLORO 7 (6) METHOXYQUINOXALINE 2 CARBONITRILE N1,N4 DIOXIDE); (3 AMINO 6 (7) TRIFLUOROMETHYLQUINOXALINE 2 CARBONITRILE N1,N4 DIOXIDE); 3 AMINO 6 (7) METHYLQUINOXALINE 2 CARBONITRILE N1,N4 DIOXIDE; 3 AMINOQUINOXALINE 2 CARBONITRILE N1,N4 DIOXIDE; IRON DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL CELL CULTURE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; EUKARYOTIC CELL; GROWTH INHIBITION; IN VITRO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYSICAL CHEMISTRY; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ELECTROCHEMISTRY; ELECTRON SPIN RESONANCE SPECTROSCOPY; FERROUS COMPOUNDS; INHIBITORY CONCENTRATION 50; IRON COMPOUNDS; LIGANDS; METALS; MICE; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; QUINOXALINES; TUBERCULOSIS;

EUKARYOTA; MURINAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 79953861812     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2010.07.005     Document Type: Article

References (35)

1. http://www.who.int/.
2. Smith P.G., Moss A.R. Epidemiology of tuberculosis. Tuberculosis, Pathogenesis, Protection and Control 1994, 47-61. ASM Press, Washington. B.R. Bloom (Ed.).
3. Sriram D., Yogeeswari P., Devakaram R. Bioorg. Med. Chem. 2006, 14:3113-3118.
4. Khan S.A., Saleem K., Khan Z. Eur. J. Med. Chem. 2007, 42:103-108.
5. Urquiola C., Vieites M., Torre M.H., Cabrera M., Lavaggi M.L., Cerecetto H., González M., López de Cerain A., Monge A., Smircich P., Garat B., Gambino D. Bioorg. Med. Chem. 2009, 17:1623-1629.
6. Urquiola C., Gambino D., Cabrera M., Lavaggi M.L., Cerecetto H., González M., López de Cerain A., Monge A., Costa-Filho A.J., Torre M.H. J. Inorg. Biochem. 2008, 102:119-126.
7. Urquiola C., Vieites M., Aguirre G., Marín A., Solano B., Arrambide G., Lavaggi M.L., Torre M.H., González M., Monge A., Gambino D., Cerecetto H. Bioorg. Med. Chem. 2006, 14:5503-5509.
8. Noblía P., Vieites M., Torre M.H., Da Costa Filho A.J., Cerecetto H., González M., Lavaggi M.L., Adachi Y., Sakurai H., Gambino D. J. Inorg. Biochem. 2006, 100:281-287.
9. Torre M.H., Gambino D., Araujo J., Cerecetto H., González M., Lavaggi M.L., Azqueta A., López de Cerain A., Monge-Vega A., Abram U., Costa-Filho A.J. Eur. J. Med. Chem. 2005, 40:473-483.
10. Vieites M., Noblía P., Torre M.H., Cerecetto H., Lavaggi M., Costa Filho A., Azqueta A., López de Cerain A., Monge A., Parajón-Costa B., González M., Gambino D. J. Inorg. Biochem. 2006, 100:1358-1367.
11. Sainz Y., Montoya M.E., Martínez-Crespo F.J., Ortega M.A., López de Ceráin A., Monge A. Arzneim.-Forsch. Drug Research 1999, 1:55-61.
12. Montoya M.E., Sainz Y., Ortega M.A., López de Ceráin A., Monge A. Il Farmaco 1998, 53:570-573.
13. Zarranz B., Jaso A., Aldana I., Monge A. Bioorg. Med. Chem. 2003, 11:2149-2156.
14. Jaso A., Zarranz B., Aldana I., Monge A. Eur. J. Med. Chem. 2003, 38:791-800.
15. Ratledge C. Tuberculosis 2004, 84:110-130.
16. Oliveira J.S., Souza E.H.S., Basso L.A., Palaci M., Dietze R., Santos D.S., Moreira I.S. Chem. Comm. 2004, 312-313.
17. Tarallo M.B., Urquiola C., Monge A., Pavan F.R., Leite C.Q., Torre M.H., Gambino D. Met. Ions Biol. Med. 2008, 10:865-872.
18. Monge A., Martínez-Crespo F.J., López de Ceráin A., Palop J.A., Narro S., Senador V., Marín A., Sáinz Y., González M., Hamilton E., Barker A.J. J. Med. Chem. 1995, 38:4488-4494.
19. Geary W.J. Coord. Chem. Rev. 1971, 7:81-91.
20. Koepp H.M., Went H., Strehlow H.Z. Z. Elektrochem. 1960, 64:483-491.
21. Gagné R.R., Koval C.A., Lisensky G.C. Inorg. Chem. 1980, 19:2854-2855.
22. Long G.J., Cranshaw T.E., Longworth G. Mössbauer Effect Reference and Data Journal 1983, 6:42-49.
23. Palomino J.C., Martin A., Camacho M., Guerra H., Swings J., Portaela F. Antimicrob. Agents Chemother. 2002, 46:2720-2722.
24. Collins L.A., Franzblau S.G. Antimicrob. Agents Chemother. 1997, 41:1004-1009.
25. Ahmed S.A., Gogal R.M., Walsh J.E. J. Immunol. Methods 1994, 170:211-224.
26. Pavan F.R., Maia P.I.S., Leite S.R.A., Deflon V.M., Batista A.A., Sato D.N., Franzblau S.G., Leite C.Q.F. Eur. J. Med. Chem. 2010, 45:1898-1905.
27. Bard J., Faulkner L.R. Electrochemical Methods 2001, J. Wiley, New York. 2nd.Edition.
28. Karayannis N.M., Pytlewski L.L., Mikulski C.M. Coord. Chem. Rev. 1973, 11:93-159.
29. Castner T., Newell G.S., Holton W.C., Slichter C.P. J. Chem. Phys. 1960, 32:668-673.
30. Wickman H.H., Klein M.P., Shirley D.A. J. Chem. Phys. 1965, 43:2113-2117.
31. Dowsing R.D., Gibson J.F. J. Chem. Phys. 1969, 50:294-303.
32. Thrane N., Trumpy G. Phys. Rev. B 1970, 1:153-155.
33. Majumder A., Pilet G., Salah El Fallah M., Ribas J., Mitra S. Inorg. Chim. Acta 2007, 360:2307-2312.
34. Sriram D., Yogeeswari P., Thirumurugan R. Bioorg. Med. Chem. Lett. 2004, 14:3923-3924.
35. Tripathi R.P., Tewari N., Dwivedi V.K. Med. Res. Rev. 2005, 25:93-131.